Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 460

Reliance and Cisco help Covacsis produce the goods

Covacsis, creator of a data analytics product for factory owners, has added to its series A funding with an undisclosed amount from the corporate investors.

Jun 3, 2014

Tarsa Therapeutics raises $7m for series B

The Novo-backed osteoporosis drug developer has now raised $35m in its series B round, and almost $100m in debt and equity since it was founded.

Jun 2, 2014

GrabTaxi hails $15m in series B funding

The taxi ordering app has now raised $25m from investors including online travel agency Qunar and will now seek to expand across Southeast Asia.

Jun 2, 2014

MedCPU computes $9.3m in Merck-funded round

A Merck investment subsidiary was among the backers for the $9.3m round, which follows a $300,000 equity investment in 2009.

May 30, 2014

XCOR blasts off for $14m series B

Space Expedition Corporation led the first close of the fledgling aerospace technology developer's series B round, raised after a $5m round in 2012.

May 30, 2014

No rebate for 51Fanli as it raises $20m

The company's series B round was funded by SIG China, and it has now secured $30m in funding.

May 30, 2014

Verizon signals closing of Newlans' $20m series B

Verizon joined Intel and Lockheed Martin in Newlans' series B round, which brings its overall equity funding to about $27m.

May 30, 2014

Twist Bioscience secures $31.1m

The company raises $26m in series B, and $5.1m in a contract with DARPA.

May 30, 2014

Brandwatch sees $22m from series B

Gorkana contributed to the round as a returning investor, boosting the social media listening firm's overall funding to more than $30m.

May 29, 2014

Powerhouse Dynamics raises efficient $6m series B

Exelon's corporate venturing subsidiary has joined the investors in the energy efficiency company, which will use the cash to advance its product.

May 23, 2014
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here